These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11044653)

  • 1. Attenuation of telomerase activity does not increase sensitivity of human melanoma cells to anticancer agents.
    Folini M; De Marco C; Orlandi L; Daidone MG; Zaffaroni N
    Eur J Cancer; 2000 Oct; 36(16):2137-45. PubMed ID: 11044653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of telomerase activity by geldanamycin and 17-allylamino, 17-demethoxygeldanamycin in human melanoma cells.
    Villa R; Folini M; Porta CD; Valentini A; Pennati M; Daidone MG; Zaffaroni N
    Carcinogenesis; 2003 May; 24(5):851-9. PubMed ID: 12771028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of telomerase activity by a hammerhead ribozyme targeting the RNA component of telomerase in human melanoma cells.
    Folini M; Colella G; Villa R; Lualdi S; Daidone MG; Zaffaroni N
    J Invest Dermatol; 2000 Feb; 114(2):259-67. PubMed ID: 10651984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of telomerase activity by a distamycin derivative: effects on cell proliferation and induction of apoptosis in human cancer cells.
    Zaffaroni N; Lualdi S; Villa R; Bellarosa D; Cermele C; Felicetti P; Rossi C; Orlandi L; Daidone MG
    Eur J Cancer; 2002 Sep; 38(13):1792-801. PubMed ID: 12175697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribozyme-mediated down-regulation of survivin expression sensitizes human melanoma cells to topotecan in vitro and in vivo.
    Pennati M; Binda M; De Cesare M; Pratesi G; Folini M; Citti L; Daidone MG; Zunino F; Zaffaroni N
    Carcinogenesis; 2004 Jul; 25(7):1129-36. PubMed ID: 14764461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase.
    Ludwig A; Saretzki G; Holm PS; Tiemann F; Lorenz M; Emrich T; Harley CB; von Zglinicki T
    Cancer Res; 2001 Apr; 61(7):3053-61. PubMed ID: 11306487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells.
    Kiyozuka Y; Yamamoto D; Yang J; Uemura Y; Senzaki H; Adachi S; Tsubura A
    Anticancer Res; 2000; 20(1A):203-12. PubMed ID: 10769656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
    Hayashidani Y; Hiyama E; Murakami Y; Sueda T
    Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of telomerase activity by hammerhead ribozyme targeting human telomerase RNA induces growth retardation and apoptosis in human breast tumor cells.
    Yeo M; Rha SY; Jeung HC; Hu SX; Yang SH; Kim YS; An SW; Chung HC
    Int J Cancer; 2005 Apr; 114(3):484-9. PubMed ID: 15551309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity and telomere length in human ovarian cancer and melanoma cell lines: correlation with sensitivity to DNA damaging agents.
    Villa R; Folini M; Perego P; Supino R; Setti E; Daidone MG; Zunino F; Zaffaroni N
    Int J Oncol; 2000 May; 16(5):995-1002. PubMed ID: 10762636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosensitization of human melanoma cells by ribozyme-mediated inhibition of survivin expression.
    Pennati M; Binda M; Colella G; Folini M; Citti L; Villa R; Daidone MG; Zaffaroni N
    J Invest Dermatol; 2003 Apr; 120(4):648-54. PubMed ID: 12648230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different effects of interferon-alpha on melanoma cell lines: a study on telomerase reverse transcriptase, telomerase activity and apoptosis.
    Maellaro E; Pacenti L; Del Bello B; Valentini MA; Mangiavacchi P; De Felice C; Rubegni P; Luzi P; Miracco C
    Br J Dermatol; 2003 Jun; 148(6):1115-24. PubMed ID: 12828737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of telomerase increases resistance of melanoma cells to temozolomide, but not to temozolomide combined with poly (adp-ribose) polymerase inhibitor.
    Tentori L; Portarena I; Barbarino M; Balduzzi A; Levati L; Vergati M; Biroccio A; Gold B; Lombardi ML; Graziani G
    Mol Pharmacol; 2003 Jan; 63(1):192-202. PubMed ID: 12488552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytostatic concentrations of anticancer agents do not affect telomerase activity of leukaemic cells in vitro.
    Akiyama M; Horiguchi-Yamada J; Saito S; Hoshi Y; Yamada O; Mizoguchi H; Yamada H
    Eur J Cancer; 1999 Feb; 35(2):309-15. PubMed ID: 10448276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of telomerase activity with hTERT antisense increases the effect of CDDP-induced apoptosis in myeloid leukemia.
    Yuan Z; Mei HD
    Hematol J; 2002; 3(4):201-5. PubMed ID: 12189566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition on telomerase activity and cytotoxic effects by cisplatin in cultured human choroidal melanoma cells.
    Cheng H; Wu Z; Zheng J; Lu G; Yan J; Liu M; Huang D; Lin J
    Yan Ke Xue Bao; 2003 Mar; 19(1):54-9. PubMed ID: 12852089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of telomerase activity by a cell-penetrating peptide nucleic acid construct in human melanoma cells.
    Villa R; Folini M; Lualdi S; Veronese S; Daidone MG; Zaffaroni N
    FEBS Lett; 2000 May; 473(2):241-8. PubMed ID: 10812083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells.
    Yokoyama Y; Takahashi Y; Shinohara A; Lian Z; Wan X; Niwa K; Tamaya T
    Cancer Res; 1998 Dec; 58(23):5406-10. PubMed ID: 9850072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribozyme-mediated inhibition of PKCalpha sensitizes androgen-independent human prostate cancer cells to cisplatin-induced apoptosis.
    Orlandi L; Binda M; Folini M; Bearzatto A; Villa R; Daidone MG; Zaffaroni N
    Prostate; 2003 Feb; 54(2):133-43. PubMed ID: 12497586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by retinoic acids.
    Choi SH; Kang HK; Im EO; Kim YJ; Bae YT; Choi YH; Lee KH; Chung HY; Chang HK; Kim ND
    Int J Oncol; 2000 Nov; 17(5):971-6. PubMed ID: 11029500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.